Studying market data including diagrams
Markets

North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Community Health ...

North Tide Capital, Llc

  • New Purchases: IPXL , AGN , ARAY ,
  • Added Positions:MYGN, KND,
  • Reduced Positions:MYL, SEM, SVU, GILD, LPNT,
  • Sold Out:CYH, VRX, PRGO, AFAM, ADUS,

For the details of NORTH TIDE CAPITAL, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=NORTH+TIDE+CAPITAL%2C+LLC

These are the top 5 holdings of NORTH TIDE CAPITAL, LLC

  1. Select Medical Holdings Corp ( SEM ) - 10,000,000 shares, 27.46% of the total portfolio. Shares reduced by 23.66%
  2. SUPERVALU Inc ( SVU ) - 18,469,921 shares, 17.87% of the total portfolio. Shares reduced by 24.61%
  3. Gilead Sciences Inc ( GILD ) - 500,000 shares, 7.42% of the total portfolio. Shares reduced by 37.5%
  4. Kindred Healthcare Inc ( KND ) - 4,250,000 shares, 6.91% of the total portfolio. Shares added by 6.25%
  5. Syneron Medical Ltd ( ELOS ) - 3,500,000 shares, 6.09% of the total portfolio.

New Purchase: Impax Laboratories Inc (IPXL)

North Tide Capital, Llc initiated holdings in Impax Laboratories Inc. The purchase prices were between $12.75 and $24.23, with an estimated average price of $17.1. The stock is now traded at around $14.10. The impact to the portfolio due to this purchase was 5.49%. The holdings were 2,000,000 shares as of 2016-12-31.

New Purchase: Allergan PLC (AGN)

North Tide Capital, Llc initiated holdings in Allergan PLC. The purchase prices were between $188.47 and $242.65, with an estimated average price of $207.16. The stock is now traded at around $248.57. The impact to the portfolio due to this purchase was 4.35%. The holdings were 100,000 shares as of 2016-12-31.

New Purchase: Accuray Inc (ARAY)

North Tide Capital, Llc initiated holdings in Accuray Inc. The purchase prices were between $4.6 and $5.98, with an estimated average price of $5.19. The stock is now traded at around $5.45. The impact to the portfolio due to this purchase was 0.95%. The holdings were 1,000,000 shares as of 2016-12-31.

Sold Out: Community Health Systems Inc (CYH)

North Tide Capital, Llc sold out the holdings in Community Health Systems Inc. The sale prices were between $4.66 and $11.47, with an estimated average price of $6.94.

Sold Out: Valeant Pharmaceuticals International Inc (VRX)

North Tide Capital, Llc sold out the holdings in Valeant Pharmaceuticals International Inc. The sale prices were between $13.6 and $24.59, with an estimated average price of $18.34.

Sold Out: Perrigo Co PLC (PRGO)

North Tide Capital, Llc sold out the holdings in Perrigo Co PLC. The sale prices were between $79.95 and $96.73, with an estimated average price of $86.74.

Sold Out: Almost Family Inc (AFAM)

North Tide Capital, Llc sold out the holdings in Almost Family Inc. The sale prices were between $36.21 and $44.85, with an estimated average price of $40.76.

Sold Out: Addus HomeCare Corp (ADUS)

North Tide Capital, Llc sold out the holdings in Addus HomeCare Corp. The sale prices were between $24.65 and $35.65, with an estimated average price of $30.82.

Reduced: Mylan NV (MYL)

North Tide Capital, Llc reduced to the holdings in Mylan NV by 62.5%. The sale prices were between $34.14 and $38.92, with an estimated average price of $37.16. The stock is now traded at around $40.75. The impact to the portfolio due to this sale was -5.19%. North Tide Capital, Llc still held 750,000 shares as of 2016-12-31.

Reduced: Select Medical Holdings Corp ( SEM )

North Tide Capital, Llc reduced to the holdings in Select Medical Holdings Corp by 23.66%. The sale prices were between $11.2 and $14.05, with an estimated average price of $12.92. The stock is now traded at around $13.15. The impact to the portfolio due to this sale was -4.56%. North Tide Capital, Llc still held 10,000,000 shares as of 2016-12-31.

Reduced: SUPERVALU Inc ( SVU )

North Tide Capital, Llc reduced to the holdings in SUPERVALU Inc by 24.61%. The sale prices were between $4.1 and $5.3, with an estimated average price of $4.74. The stock is now traded at around $3.86. The impact to the portfolio due to this sale was -3.28%. North Tide Capital, Llc still held 18,469,921 shares as of 2016-12-31.

Reduced: Gilead Sciences Inc ( GILD )

North Tide Capital, Llc reduced to the holdings in Gilead Sciences Inc by 37.5%. The sale prices were between $71.61 and $78.47, with an estimated average price of $74.33. The stock is now traded at around $67.55. The impact to the portfolio due to this sale was -2.58%. North Tide Capital, Llc still held 500,000 shares as of 2016-12-31.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

SEM GILD

Other Topics

Stocks

Latest Markets Videos